Omada Health, Inc.
OMDA
$22.14
$0.180.82%
NASDAQ
| 06/30/2025 | |||||
|---|---|---|---|---|---|
| Revenue | 11.66% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 11.66% | ||||
| Cost of Revenue | -8.66% | ||||
| Gross Profit | 26.35% | ||||
| SG&A Expenses | 9.96% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 3.72% | ||||
| Operating Income | 48.26% | ||||
| Income Before Tax | 43.79% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | 43.79% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 43.79% | ||||
| EBIT | 48.26% | ||||
| EBITDA | 57.64% | ||||
| EPS Basic | 78.92% | ||||
| Normalized Basic EPS | 78.91% | ||||
| EPS Diluted | 78.92% | ||||
| Normalized Diluted EPS | 78.91% | ||||
| Average Basic Shares Outstanding | 166.61% | ||||
| Average Diluted Shares Outstanding | 166.61% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||